Knight Therapeutics IncKnight Therapeutics IncKnight Therapeutics Inc

Knight Therapeutics Inc

No trades
See on Supercharts

Price target

5.670.000.00%
The 7 analysts offering 1 year price forecasts for KHTRF have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to KHTRF in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


KHTRF EPS for the last quarter is −0.10 USD despite the estimation of 0.01 USD. In the next quarter EPS is expected to reach −0.00 USD. Track more of Knight Therapeutics Inc financials and stay on top of what is up with the company.
In the next quarter Knight Therapeutics Inc revenue is expected to reach ‪78.19 M‬ USD. Check out Knight Therapeutics Inc revenue and earnings and make informed decisions.
According to analysts, KHTRF price target is 5.67 USD with a max estimate of 7.27 USD and a min estimate of 4.47 USD. Check if this forecast comes true in a year, meanwhile watch Knight Therapeutics Inc stock price chart and keep track of the current situation with KHTRF news and stock market news.
We've gathered opinions of 7 analysts rating KHTRF stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.